MedTrace Logo

Uric Acid Levels and Migraine in Children

NCT06966037 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2025-05-11

No results posted yet for this study

Summary

Migraine is recognized as one of the most prevalent neurological disorders. The exact pathophysiological mechanisms underlying migraine have not yet been fully elucidated. The present study aims to compare serum uric acid levels between pediatric patients with migraine and a control group. Additionally, this study seeks to explore the potential relationship between migraine attack frequency and gender differences in pediatric patients

Conditions

  • Migraine in Children

Sponsors & Collaborators

  • Aysen Orman

    lead OTHER

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2025-01-01
Completion
2025-04-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06966037 on ClinicalTrials.gov